Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 76Sarcoma 72Burkitt Lymphoma 59Lymphoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Non-Hodgkin 53Lymphoma, Follicular 49Lymphoma, Mantle-Cell 48Leukemia 48Lymphoma, Large-Cell, Immunoblastic 47Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Acute 43Hodgkin Disease 42Myelodysplastic Syndromes 41Multiple Myeloma 40Recurrence 39Leukemia, Myeloid, Chronic-Phase 32Leukemia, Myeloid, Accelerated Phase 31Blast Crisis 30Neoplasms, Plasma Cell 28Sarcoma, Ewing 25Rhabdomyosarcoma 25Osteosarcoma 24Myeloproliferative Disorders 24Neuroblastoma 23Leukemia, Myelomonocytic, Chronic 21Congenital Abnormalities 21Melanoma 20

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Cyclophosphamide × Sarcoma × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡